IRIS
PORRECA, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.733
EU - Europa 4.849
AS - Asia 2.929
SA - Sud America 84
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 9
Totale 13.632
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.692
CN - Cina 1.059
SG - Singapore 959
UA - Ucraina 906
IE - Irlanda 883
SE - Svezia 755
TR - Turchia 614
IT - Italia 606
GB - Regno Unito 515
FR - Francia 347
DE - Germania 343
FI - Finlandia 194
IN - India 185
RU - Federazione Russa 170
BR - Brasile 71
BE - Belgio 33
CA - Canada 32
TW - Taiwan 23
VN - Vietnam 19
AT - Austria 18
CZ - Repubblica Ceca 14
EU - Europa 11
KR - Corea 11
PL - Polonia 11
NL - Olanda 9
AU - Australia 8
GR - Grecia 8
HK - Hong Kong 8
IL - Israele 7
IR - Iran 7
JP - Giappone 6
RO - Romania 6
AR - Argentina 5
BD - Bangladesh 5
ES - Italia 5
MX - Messico 5
TH - Thailandia 5
EC - Ecuador 4
ID - Indonesia 4
IQ - Iraq 4
KE - Kenya 4
LT - Lituania 4
CH - Svizzera 3
DK - Danimarca 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
ZA - Sudafrica 3
CU - Cuba 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
HR - Croazia 2
JO - Giordania 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
RS - Serbia 2
SR - Suriname 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
Totale 13.632
Salva come PNG Salva come JPEG
Città #
Chandler 1.099
Jacksonville 1.040
Dublin 868
Singapore 701
Princeton 437
Southend 385
Izmir 325
Nanjing 290
Dearborn 247
Wilmington 222
Cambridge 170
Ashburn 168
Santa Clara 165
Beijing 158
Altamura 138
Ann Arbor 131
Chieti 126
Nanchang 98
Boardman 81
Woodbridge 80
Hebei 65
Shenyang 54
Kunming 48
Los Angeles 48
Jiaxing 43
Tianjin 42
Helsinki 40
New York 35
Washington 33
Grevenbroich 32
Brussels 31
Pescara 30
Changsha 28
Hangzhou 28
San Mateo 28
Munich 26
Houston 25
Norwalk 25
Falls Church 24
Jinan 21
Guangzhou 20
Leawood 20
Seattle 20
Augusta 18
Toronto 17
Orange 16
Nuremberg 15
Dong Ket 14
Ningbo 14
Hefei 13
Auburn Hills 12
Kocaeli 12
Lanzhou 12
Moscow 12
Taipei 12
Teramo 11
Hanover 10
Kraków 10
Zhengzhou 10
Vienna 9
Bellante 8
Brno 8
Changchun 8
Edinburgh 8
Rome 8
Shanghai 8
Cologno Monzese 7
Milan 7
Monmouth Junction 7
Montenero Di Bisaccia 7
San Giovanni 7
Sant'onofrio 7
São Paulo 7
Taizhou 7
Ardabil 6
Hong Kong 6
Pianella 6
Romola 6
Silvi 6
Sydney 6
Tappahannock 6
Bangkok 5
Buffalo 5
Hanoi 5
Olomouc 5
Pune 5
Rochester 5
Altino 4
Baghdad 4
Dhaka 4
Fuzhou 4
Mcallen 4
Montesilvano Marina 4
Nairobi 4
New Taipei 4
Paris 4
Plymouth 4
Redmond 4
Redwood City 4
Tokyo 4
Totale 8.140
Salva come PNG Salva come JPEG
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 199
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism 118
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 116
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 114
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 111
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease. 110
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 105
Apixaban for extended treatment of venous thromboembolism 103
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 101
Pravastatin upregulates TGF-b1 in THP-1 human macrophage: effect on scavenger receptor class A expression. 100
Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue 100
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits. 99
Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients 99
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 97
INCREASED TYPE I AND TYPEII TRANSFORMING GROWTH FACTOR-β RECEPTOR EXPRESSION DURING CHOLESTEROL CHALLENGE. 96
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 96
Cholesterol feeding modulates type I and type II TGF-beta receptor expression and fibrogenic vascular remodelling in C57BL/6 mice (pubbl. su Atherosc.) 95
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 95
Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. 94
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 91
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 91
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 90
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 90
ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS 89
Prognostic value of nondipping and morning surge in elderly treated hypertensive patients with controlled ambulatory blood pressure 89
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 88
Study of the gastric mucosal reactivity in patients with urticaria induced by nonsteroidal anti-inflammatory drugs. 88
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 88
AORTIC ANTIOXIDANT DEFENSE MECHANISMS IN RABBITS SUBJECTED TO SUPRARENAL AORTIC COARCTATION HYPERTENSION 88
Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge 87
Oral apixaban for the treatment of acute venous thromboembolism 87
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 86
PRAVASTATIN UP-REGULATES TGF-B1 IN THP-1 HUMAN MACROPHAGES :EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION 85
Circulating leptin is associated with oxidized LDL in postmenopausal women. 85
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 85
Oral rivaroxaban for symptomatic venous thromboembolism 85
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 84
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients 84
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 83
Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells 83
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 83
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. 83
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 83
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 82
Myocardial antioxidant defence mechanisms: time-related changes after reperfusion of the ischemic rat heart 82
New method for the extraction of DNA from white blood cells for the detection of common genetic variants associated with thrombophilia 81
CYCLOOXYGENASE-2-DERIVED PROSTACYCLIN RESTRAIN PLATELET THROMBOXANE BIOSYNTHESIS IN TOLL-LIKE RECEPTOR 4 POLYMORPHISM 81
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. 81
Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients 81
Determinants of platelet activation in Alzheimer's disease 81
Transforming growth factor beta1 induces IL-1 receptor antagonist gene expression and production in rat vascular smooth muscle cells 80
The hematocrit and platelet target in polycytemia vera 80
Iron status and oxidative stress in the aged rabbit heart 80
Rivaroxaban or aspirin for extended treatment of venous thromboembolism 80
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 80
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 79
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 79
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 78
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 78
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 78
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 78
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 78
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. 78
The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. 78
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 78
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 78
Protein kinase C pathway and proliferative response of aged and young rat vascular smooth muscle cell. 77
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 77
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 77
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 76
Antioxidant properties of ticlopidine on human low density lipoprotein oxidation 76
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients 76
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 76
Non-O blood group and outcomes of in vitro fertilization 76
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 75
Systemic oxidative stress status in patients with ischemic heart disease 75
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 75
Rivaroxaban for cancer-associated cardiac thrombosis 75
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients 75
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids 74
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 74
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 73
Induction of alkaline phosphatase generation by IL-1ß and LPS on human neutrophils and macrophages and lack of inhibition by interleukin-1 receptor antagonist. 72
“ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS" 72
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 72
EFFECTS OF NABUMETONE AND ITS ACTIVE METABOLITE 6-METHOXY-2-NAPHTHYL ACETIC ACID ON HUMAN BLOOD PROSTAGLANDIN H SYNTHASES. 71
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 71
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 71
Time course of aortic antioxidant defense mechanisms in rabbit experimental atherosclerosis 71
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 71
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 71
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 71
IS THE SIMPLEST EXPLANATION USUALLY THE CORRECT ONE? A CLINICAL APPLICATION OF THE "OCKHAM'S RAZOR" 71
Vascular changes in hypertensive patients with different left ventricular geometry 70
Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. 70
Vascular non-protein thiols: prooxidants or antioxidants in atherogenesis? 70
[Physiopathological bases of the medical treatment of portal hypertension]. 70
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 70
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 70
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 70
Totale 8.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.449
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020472 0 0 0 0 0 0 0 0 72 150 228 22
2020/20211.274 171 15 222 26 104 268 15 20 97 163 79 94
2021/20221.026 53 13 11 236 77 24 25 81 68 17 101 320
2022/20233.091 261 403 179 331 303 627 174 226 404 39 88 56
2023/20241.369 94 48 124 45 108 391 296 55 31 38 7 132
2024/20252.030 241 625 537 56 65 138 90 175 103 0 0 0
Totale 14.199